Want to see HVRRY full AI Analyst Report?
HVRRY Stock Chart & Stats
$47.27
-$0.17(-0.38%)
At close: 4:00 PM EST
$47.27
-$0.17(-0.38%)
Day’s Range― - ―
52-Week Range$43.32 - $54.49
Previous CloseN/A
Volume2.97K
Average Volume (3M)1.17K
Market Cap
$34.55B
Enterprise Value$43.14K
Total Cash (Recent Filing)$1.14B
Total Debt (Recent Filing)$4.15B
Price to Earnings (P/E)3.3
Beta0.36
Next Earnings
Aug 12, 2026EPS Estimate
1.07Next Dividend Ex-DateN/A
Dividend Yield3.57%
Share Statistics
EPS (TTM)3.96
Shares Outstanding723,582,800
10 Day Avg. Volume1,549
30 Day Avg. Volume1,170
Financial Highlights & Ratios
PEG Ratio1.41
Price to Book (P/B)2.48
Price to Sales (P/S)1.34
P/FCF Ratio5.64
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)4.46
Revenue Forecast (FY)$32.13B
Bulls Say, Bears Say
Bulls Say
Capitalization & SolvencyA 254% solvency ratio and rising equity provide a durable capital buffer to absorb catastrophes, support risk-taking and regulatory compliance, and permit disciplined capital returns or growth spending without forcing reactive balance-sheet measures over the medium term.
P&C Underwriting StrengthA sub-87% combined ratio indicates consistent underwriting profitability and effective pricing and claims management. Sustained lower loss ratios reduce reliance on investment income and improve earnings stability across cycles, supporting durable core profitability.
Improving Leverage & Cash GenerationLower debt-to-equity alongside steady operating cash flow (~$4.9B–$5.9B historically) strengthens financial flexibility for retrocession, reserve strengthening and opportunistic deployment. This combination supports resilient operations and strategic execution over months.
Bears Say
Free Cash Flow VolatilitySharp swings in free cash flow undermine predictability for dividends, buybacks, or capital deployment. If driven by timing, claims or investment timing, it can constrain strategic initiatives and increase funding risk during adverse underwriting or market periods over the medium term.
Rate Softening / Pricing PressureOngoing rate weakening across renewals can compress underwriting margins and slow premium growth. Persistent negative risk-adjusted pricing raises the bar for expense and claims discipline and could depress medium-term profitability if market repricing does not reverse.
Structured Reinsurance Volume DeclineA meaningful drop in structured reinsurance—often higher-margin and relationship-driven—reduces revenue diversity and can lower net premiums and fee income. Continued weakness here would pressure growth and underwriting mix over the coming renewal cycles.
Hannover Rueck SE News
HVRRY FAQ
What was Hannover Rueck SE’s price range in the past 12 months?
Hannover Rueck SE lowest stock price was $43.32 and its highest was $54.49 in the past 12 months.
What is Hannover Rueck SE’s market cap?
Hannover Rueck SE’s market cap is $34.55B.
When is Hannover Rueck SE’s upcoming earnings report date?
Hannover Rueck SE’s upcoming earnings report date is Aug 12, 2026 which is in 26 days.
How were Hannover Rueck SE’s earnings last quarter?
Hannover Rueck SE released its earnings results on May 11, 2026. The company reported $1.156 earnings per share for the quarter, missing the consensus estimate of $1.179 by -$0.023.
Is Hannover Rueck SE overvalued?
According to Wall Street analysts Hannover Rueck SE’s price is currently Overvalued.
Does Hannover Rueck SE pay dividends?
Hannover Rueck SE pays a Annually dividend of $2.449 which represents an annual dividend yield of 3.57%. See more information on Hannover Rueck SE dividends here
What is Hannover Rueck SE’s EPS estimate?
Hannover Rueck SE’s EPS estimate is 1.07.
How many shares outstanding does Hannover Rueck SE have?
Hannover Rueck SE has 723,582,800 shares outstanding.
What happened to Hannover Rueck SE’s price movement after its last earnings report?
Hannover Rueck SE reported an EPS of $1.156 in its last earnings report, missing expectations of $1.179. Following the earnings report the stock price went down -2.577%.
Which hedge fund is a major shareholder of Hannover Rueck SE?
Currently, no hedge funds are holding shares in HVRRY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hannover Rueck SE Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.00%
12-Months-Change
Fundamentals
Return on Equity
73.88%
Trailing 12-Months
Asset Growth
7.93%
Trailing 12-Months
Company Description
Hannover Rueck SE
Hannover Rück SE, through its network of global subsidiaries, functions as a prominent international supplier of extensive reinsurance solutions and related services. Its business operations are primarily divided into two main areas: Property & Casualty Reinsurance and Life & Health Reinsurance. Within the Property & Casualty division, the company delivers a wide array of offerings. These include general property and casualty coverage, bespoke facultative reinsurance, protection against major catastrophic events (known as catastrophe XL), intricate structured reinsurance programs, and innovative insurance-linked securities. Moreover, it devises specialized risk management strategies for specific industries such as agriculture, livestock, and bloodstock; aviation and space endeavors; marine and offshore energy ventures; and complex exposures like credit, surety, and political risks. In the Life & Health sector, Hannover Rück provides reinsurance for various products, including group and individual credit life policies, enhanced annuity options, group life and health plans, and Takaful (Islamic insurance) products. It further extends its expertise to risk solutions concerning critical illness, disability, general health, longevity, long-term care, mortality, and morbidity. Beyond its core reinsurance activities, the firm also offers a suite of financial solutions. These encompass funding for new business initiatives, unlocking embedded value, providing crucial reserve and solvency relief, and facilitating the divestiture of non-essential business segments. Established in 1966 and based in Hanover, Germany, the company adopted its current name, Hannover Rück SE, in March 2013, having previously been known as Hannover Rückversicherung AG. It operates as a subsidiary of Talanx AG.
Technical Analysis
American International Group
―
Arch Capital Group
―
Everest Group
―
Reinsurance Group
―
Renaissancere Holdings
―
Ownership Overview
―
Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors










